Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 640 shares of Common Stock at $538.3425 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 49,373.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,018 shares of Common Stock at $539.8906 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 48,355.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,128 shares of Common Stock at $541.2376 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 46,227.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 983 shares of Common Stock at $542.1444 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 45,244.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,012 shares of Common Stock at $543.3196 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 44,232.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 439 shares of Common Stock at $544.1783 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 43,793.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 560 shares of Common Stock at $545.5158 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 43,233.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 156 shares of Common Stock at $547.0047 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 43,077.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 452 shares of Common Stock at $548.1282 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 42,625.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 872 shares of Common Stock at $548.8997 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 41,753.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 520 shares of Common Stock at $549.6867 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 41,233.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 400 shares of Common Stock at $550.7926 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 40,833.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Sold 280 shares of Common Stock at $552.3624 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 40,553.00 | transaction_form_type: 4 | Footnotes: F1, F14
• Sold 40 shares of Common Stock at $553.49 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F16
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F17
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F18
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-06-26 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 106,218.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 349,192 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2027-03-15 | Exercise: 2023-03-15 | shares_owned_after: 349,192.00 | Footnotes: F19

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $547.39 to $548.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $548.41 to $549.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $549.43 to $550.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $550.56 to $551.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $552.05 to $552.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F16: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F17: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F18: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F19: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F2: This transaction was executed in multiple trades at prices ranging from $538.18 to $538.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $539.66 to $540.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $540.67 to $541.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $541.67 to $542.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $542.74 to $543.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $543.825 to $544.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $545.23 to $546.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $546.39 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.